 In January 2016 the company spun out its biopharmaceutical operations into Albumedix.In June 2020 the business announced it would acquire buy Ireland-based PrecisionBiotics for $90 million.The Novozymes class A share capital is held by Novo A/S, a wholly owned subsidiary of the Novo Nordisk Foundation.